Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

NCT04617743 is registered in ClinicalTrials.gov with Istanbul Medeniyet University as lead sponsor.

NCT NCT04617743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04617743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
Lead sponsor
Istanbul Medeniyet University
Phase
Observational
Overall status
Completed
Start date
November 26, 2020
Completion date
November 1, 2022
Enrollment
500 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer recurrent, non-invasive bladder urothelial carcinoma